Component: (Network and Table)
Network
00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS
(http://www.endocyte.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001235007 (http://www.sec.gov/CIK)
Statement Of Cash Flows [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Statement Of Cash Flows [Abstract]
 
 
 
Operating activities
 
 
 
Net income (loss)
(43,887,573) 
(41,269,749) 
5,459,477  
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
Depreciation
919,809  
886,710  
857,055  
Stock-based compensation
9,322,127  
6,920,220  
8,025,261  
Loss on disposal of property and equipment
0  
10,639  
6,100  
Accretion of bond premium
395,116  
1,310,238  
1,615,063  
Net realized foreign currency translation loss
0  
51,944  
0  
Change in operating assets and liabilities:
 
 
 
Receivables
191,555  
856,372  
5,490,605  
Prepaid expenses and other assets
(517,318) 
(96,582) 
2,711,331  
Accounts payable
(252,605) 
(60,713) 
(3,700,175) 
Accrued wages, benefits and other liabilities
(771,866) 
(777,204) 
(2,923,537) 
Deferred revenue
(50,000) 
(50,000) 
(59,746,948) 
Net cash used in operating activities
(34,650,755) 
 
(32,218,125) 
 
(42,205,768) 
 
Investing activities
 
 
 
Purchases of property and equipment
(713,839) 
(341,616) 
(1,501,744) 
Proceeds from disposal of property and equipment
0  
0  
10,000  
Purchases of investments
(139,932,358) 
(86,281,946) 
(149,370,678) 
Proceeds from sale and maturities of investments
190,765,053  
88,114,199  
82,302,191  
Net cash provided by investing activities
50,118,856  
 
1,490,637  
 
(68,560,231) 
 
Financing activities
 
 
 
Stock repurchase
(164,472) 
(57,274) 
(3,814) 
Proceeds from public offering
0  
0  
101,904,977  
Proceeds from the exercise of stock options
261,082  
379,290  
1,290,886  
Proceeds from stock purchases under employee stock purchase plan
231,859  
305,003  
299,229  
Net cash provided by financing activities
328,469  
 
627,019  
 
103,491,278  
 
Effect of exchange rate
0  
(1,352) 
(38,776) 
Net increase (decrease) in cash and cash equivalents
15,796,570  
 
(30,101,821) 
 
(7,313,497) 
 
Cash and cash equivalents at beginning of period
15,431,622  
45,533,443  
52,846,940  
Cash and cash equivalents at end of period
31,228,192  
 
15,431,622  
 
45,533,443